Severe skeletal muscle damage following the administration of mesalazine to a patient with ulcerative colitis.
Tabata
Nobutada
N
Department of Pediatrics, Kinki University School of Medicine, Osaka-Sayama, Osaka 589-8511, Japan. batayann@star.so-net.jp
Sugimoto
Keisuke
K
Ueda
Satoshi
S
Sakata
Naoki
N
Okada
Mitsuru
M
Miyake
Toshiharu
T
Shinohara
Tohru
T
Yagi
Makoto
M
Satou
Takao
T
Takemura
Tsukasa
T
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects*; D002648:Child; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D005260:Female; D006801:Humans; D019804:Mesalamine / Q000008:administration & dosage / Q000009:adverse effects*; D018482:Muscle, Skeletal / Q000187:drug effects* / Q000473:pathology; D009135:Muscular Diseases / Q000139:chemically induced* / Q000473:pathology; D014949:Wounds, Nonpenetrating / Q000139:chemically induced / Q000473:pathology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D019804:Mesalamine